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Primary hyperparathyroidism (PHPT) is not an uncommon disease in the western countries. In Thailand, on the contrary, PHPT
was a rare condition with various clinical presentations. All 45 PHPT patients who underwent parathyroidectomy at the Depar-
tment of Surgery, Siriraj Hospital during January 1997 and December 2007 were retrospectively reviewed. Demographic data,
clinical presentation,localizations imaging, operativeprocedures, ﬁndings,complications, andpathological reportswereanalyzed.
Median age was 49 years (range 15–89 years) with female: male ratio of 3:1. Only one patient (2.2%) was asymptomatic PHPT. Of
all symptomatic cases, 30 (66.7%) had skeletal symptoms, 7 (15.6%) had renal impairment, and 39 (86.7%) had mixed symptoms.
42 patients (93.3%) had parathyroid scan and all had bilateral exploration of the neck. Postoperative hungry bone syndrome
was noted in 10 patients (22%). On followup, skeletal and neuropsychiatric symptoms were improved but the renal impairment
was remained. The s small number of asymptomatic PHPT in our study may refer to large number of underdiagnosed PHPT
in general population. The guideline for screening serum calcium for diagnosis of PHPT in Thai populations will improve the
long-term consequence of the disease but will need further information to identify the target group.
1.Introduction
Primary hyperparathyroidism (PHPT) is a condition caused
by excessive and uncontrolled secretion of parathyroid hor-
mone by the abnormal parathyroid gland(s). In the west, this
condition is common between the ﬁfth to seventh decades of
life with female:male ratio of 3:1. Incidence of PHPT was
estimated to be 20 per 100,000 [1, 2] and more than 80% of
PHPT cases is asymptomatic at the time of diagnosis [3–5].
TheﬁrstsignofPHPTiselevatedserumcalciumonaroutine
biochemical evaluation.
On the contrary, PHPT is relatively rare disease in Thai-
land. There was no previous published data regarding PHPT
in Thai populations. Most of PHPT patients in Thailand
presented with multiple somatic signs and symptoms of
many systems including skeletal system (bone pain, osteitis
ﬁbrosa cystica, pathological fracture, and proximal muscle
weakness), renal system (recurrent nephrolithiasis, renal fail-
ure), nervous system (psychosis, mental state change), GI
system (peptic ulcer, constipation, and pancreatitis), and
hypertension.
Understanding the clinical presentation and its course of
PHPT in Thai populations would beneﬁt in future detection
and management of PHPT in Thailand. In addition, we can
compare these information to other Asian countries where
screening of hypercalcemia is not the general practice.
2.MaterialsandMethods
A retrospective descriptive study of patients with PHPT who
underwent parathyroidectomy at Department of Surgery,
SirirajHospitalduringJanuary1997andDecember2007was
carried out. Patients with recurrent primary hyperparathy-
roidism, secondary and tertiary hyperparathyroidism were
excluded. The study was approved by the Institutional Re-
view Board with the exemption of informed consent.2 International Journal of Endocrinology
Table 1: Characteristic of patients by age group and gender.
Age group (years) Female Male
<30 5 1
31–40 5 5
41–50 8 1
51–60 6 2
61–70 6 1
>71 4 1
Total 34 11
All related medical data including demographic data,
clinical presentations, comorbidities, localizations of abnor-
mal parathyroid glands, operations and their ﬁndings, and
pathology and complications were reviewed. Demographic
data consisted of age, sex, and other diagnosis. Clinical pre-
sentations were divided into diﬀerent physiological systems
as skeletal, renal, neuromuscular, neuropsychiatric, gastro-
intestinal systems, and other nonspeciﬁcs symptoms. Data
on blood chemistry included preoperative and postoperative
serum calcium (total and ionized), phosphate, alkaline phos-
phatase, creatinine, and parathyroid hormone. Postoperative
blood chemistry was collected at 3–12 months. Imaging
modalities for localization and their accuracy when compar-
ing to operative ﬁndings were noted.
Alldatawerepreparedandanalyzedstatisticallyusingthe
Statistical Package for the Social Sciences program version
13.0 for Windows (SPSS Inc, Chicago, IL, USA). Categorical
data were calculated as percentages and were analyzed.
3. Results
45 new cases of PHPT underwent parathyroidectomy at
Siriraj Hospital between January 1997 and December 2007.
The age ranged from 15 to 89 years (Average 49 years) with
female: male ratio of 3:1. Disease prevalence was distributed
in all age group as shown in Table 1.M e a nf o l l o w - u pp e r i o d
was 3 years (range 6 months to 7 years). There was no mor-
tality in this study.
In this study, there was only 1 asymptomatic patient
(2.2%) at the time of diagnosis. The majority of 44 pa-
tients (97.8%) were presented with various symptoms. In
this group 39 patients (86.7%) had mixed multisystem sym-
ptoms. The most common presentation was skeletal symp-
toms (30 patients, 66.7%) with one-ﬁfth of all patients had
pathological fracture. The second most common clinical
featureswereinrenalsystem.In21patients(46.7%)whohad
renal symptoms, 7 patients (15.6%) had renal function im-
pairment. The only one patient who presented with a neck
masswasoneoffourofparathyroidcarcinoma.Interestingly,
2 patients were diagnosed during postpartum period due to
fetal hypocalcemia. Details of clinical presenting symptoms
were shown in Table 2.
In this study, median serum calcium at the time of diag-
nosis was 13.1mg/dL (range 8.1–22). Median parathyroid
hormone level was 341pg/mL (range 107–2490pg/mL).
It was noted that the highest level of serum parathyroid
Table 2: Details of symptoms in according to system.
Symptoms Percentage (n)
Asymptomatic hypercalcemia 2.2 (1)
Skeletal symptoms
Pathological fracture 20 (9)
Radiological changes 31.1 (14)
Osteoporosis 33.3 (15)
Chondrocalcinosis 2.2 (1)
Total 66.7 (30)
Renal symptoms
Renal calculi, ureteric calculi 28.9 (13)
Renal insuﬃciency (Cr > 2) 15.6 (7)
Polyuria 11.1 (5)
Total 46.7 (21)
Neuromuscular symptoms
Muscle weakness 17.8 (8)
Myalgia 24.4 (11)
Peripheral neuropathy 2.2 (1)
Total 44.4 (20)
Neuropsychiatric symptoms
Alteration of consciousness 8.9 (4)
Psychosis 2.2 (1)
Total 11.1 (5)
Other symptoms
Weight loss 11.1 (5)
Abdominal pain 4.4 (2)
Peptic ulcer 8.9 (4)
Constipation 11.1 (5)
Chronic pancreatitis 2.2 (1)
Neck mass 2.2 (1)
Fetal hypocalcemia 4.4 (2)
Anorexia 2.2 (1)
Total 36.7 (17)
hormone detected was 2490pg/mL and was found in patient
with parathyroid adenoma not carcinoma. Elevated alkaline
phosphatase was documented in 36 patients (80%) with the
median of 453unit/L (range 60–3unit/L). As in this study
there was a high proportion of parathyroid cancer, we also
presentedtheﬁguresofbloodchemistryofallcasesandcases
excluding carcinoma to be compared (Table 3).
Preoperative localization with the parathyroid scan (Tc-
99m pertechnetate/Tc-99m MIBI subtraction and dual
p h a s eT c - 9 9mM I B Ia n dS P E C T )w a ss e l e c t e da sap r i m a r y
investigation in 42 patients (93.3%). The parathyroid scan
yielded true positive scan in 39 patients (92.9%). Of three
patients who did not have parathyroid scan, two had ultra-
sound scan and one had no preoperative imaging for locali-
zation. One patient who had negative parathyroid scan had
disease gland localized by MRI scan.
All patients had standard collar incision with bilateral
neck exploration. The abnormal parathyroid gland can beInternational Journal of Endocrinology 3
Table 3: Blood chemistry in pre- and postoperative status.
Parameters Preoperative
(45 patients)
Preoperative
(41 patients, excluded
parathyroid carcinoma)
Postoperative
(45 patients)
Postoperative
(41 patients, excluded
parathyroid carcinoma)
Total calcium
(8.1–10.4mg/dL) 13.1 (8.1–22) 13.1 (8.1–22) 9.15 (8–13) 9.19 (8–11)
Ionized calcium
(4.6–5.2mg/dL) 6.2 (3.8–10.8) 6.2 (3.8–10.8) 4.5 (3.6–8.9) 4.7 (3.6–8.9)
Phosphate
(2.2–5mg/dL) 2.4 (1.2–7.9) 2.4 (1.2–7.9) 2.9 (1.5–4.6) 3.7 (1.5–2.3)
PTH (15–65pg/mL) 341 (107–2490) 330.5 (107–2490) 46.7 (5.6–1412) 58.5 (5.6–189)
Alkaline phosphatase
(39–117unit/L) 449 (35–3384) 420 (35–3384) 190 (57–836) 267 (57–836)
identiﬁed in 97.8% (44 patients). Median sternotomy was
performed due to location of the disease gland in the medi-
astinum in one patient. Pathological examination revealed
single adenoma in 79.5% (n = 35), hyperplasia 11% (n = 5),
and parathyroid carcinoma 9% (n = 4).
On the postoperative course, 10 patients (22%) had
severe and prolonged hypocalcemia, known as hungry bone
syndrome. This condition was well related to preoperatively
high level of alkaline phosphatase (median 606unit/L, range
320–3384unit/L). In addition, hungry bone syndrome was
also found in patients who had severe skeletal symptoms
and signs. There was no report of recurrent laryngeal nerve
injury,postoperativebleeding,andwoundinfection.Onepa-
tient had thoracic duct injury and was treated successfully
without surgical correction.
All patients with pathological fracture (n = 9) had sig-
niﬁcant clinical improvement demonstrated by well union of
the fracture sites within 5–20 months postoperatively. One
patient who had preoperative psychosis was gradually im-
proved. However, patients with nephrocalcinosis did not
show any improvement of the kidney. Most of the patients
with preoperative renal failure (serum creatinine > 2) also
did not get beneﬁt on the renal function after parathyroidec-
tomy.
4. Discussion
PHPT was traditionally described with classical symptoms
and signs as painful bones, renal stones, abdominal groans,
andpsychicmoan[6].However,aftermeasurementofserum
calcium levels was included in the routine check-up program
inmanydevelopedcountries,numberofasymptomaticcases
has been increasing, therefore symptomatic PTHT has be-
come the minority.
In many Asian countries, routine testing of serum cal-
cium is still not in a general practice. Clinical reports from
India and Taiwan show all higher percentage of symptomatic
PHPT compared to the West [7–9]. In Thailand serum
calcium monitoring is also not a routinely practice, therefore
our study documented only 2.2% of asymptomatic presenta-
tioninPHPT.TherealincidenceofPHPTinThaipopulation
is unknown. However, we believed that PTHT is deﬁnitely
underdiagnosed and delay detected in Thailand.
Age distribution of PHPT in our study seems to expand
in every age group (15–89 years) which is similar to India
but not Taiwan. To design a screening age group of PHPT for
early detection in Thailand would need further information.
Skeletal-and-renal related symptoms were the leading
clinical presentation of symptomatic PHPT. In this study
there were 20% of patients with pathological fracture and
15.6% with renal impairment. These clinical features repre-
sentedthelatediagnosisandshowedsimilarpatternofsymp-
toms to other Asian countries. Although all fractures were
reunioned after parathyroidectomy, the period of treatment
was relatively longer than in healthy bone (5–20 months).
Anyhow, the renal consequences such as renal calculi and
impairment may not improve after parathyroidectomy.
Interestingly, on analysis without patients with parathy-
roid cancer, the blood chemistry on diagnosis showed no
signiﬁcant diﬀerent. These may also refer that late diagnosis
of PHPT could mimic the clinical pictures of parathyroid
carcinoma.
Otherﬁndingsofhighnumberofsymptomaticcaseslead
us to quest that there may be many more hidden asymp-
tomatic cases in Thai population. However, the answer will
fall into two situations. First, asymptomatic cases in Thai
were distributed in all age group, this situation made screen-
ingprotocoldiﬃcultduetovariedtargetgroupandlowcost-
eﬀectiveness. The second situation, if asymptomatic cases
in Thai were clustered in age group 55–75 years. The next
question was that do screening and parathyroidectomy in
those patients really reduced consequences of PHPT, as some
of the symptomatic cases were young and will be excluded
in screening protocol. However, authors believed that in
unknown situation, screening serum calcium in female age
>55 or menopausal age group would gain some beneﬁts.
Thus, we encourage addition of serum calcium screening for
female age >55 who will have routine blood check up for
other purposes.
Localization method with parathyroid scan had been
reported with accuracy 50–90% [10]. In this study, 93.3% of
cases were localized with parathyroid scan with accuracy of
92.9%. Bilateral exploration was still the operation of choice
due to not very high volume of PHPT in our experience.
With bilateral exploration, there was still one case where
the abnormal parathyroid gland could not be identiﬁed.4 International Journal of Endocrinology
This patient was also the one who had negative preoperative
imaging localization.
Finally, pathological ﬁndings of the abnormal parathy-
roid gland in this study were revealed single adenoma in
79.5% (n = 35), hyperplasia 11% (n = 5), and parathyroid
carcinoma 9% (n = 4). This high proportion of parathyroid
cancer may lead us to think of possibility of many undi-
agnosed benign cases in the population. In Taiwan study,
with screening of serum calcium in 4359 healthy individuals
aged 21–94 years, at least 4 cases were diagnosed with PHPT,
representing a minimum estimated prevalence of 92 per
100,000. This ﬁgure is not very far from report from the wes-
tern countries.
5. Conclusion
Our experience with PHPT from a single institute in Thai-
land was likely the late diagnosis PHPT with various severe
symptoms. Anyway to improve our detection will deﬁnitely
beneﬁt the patient in duration of treatment and prevention
of permanent damage to major organs. Clinical features of
late diagnosis of benign PHPT may also mimic the presen-
tation of parathyroid carcinoma. According to our ﬁndings,
there might be the stage of underdetection of asymptomatic
hypercalcemia. The guideline for screening serum calcium
in order to diagnose PHPT in Thai populations would need
further information to develop.
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